Cointime

Cayman Chemical

company

About

Cayman Chemical is a biotechnology firm that provides assay kits, antibodies, proteins, biochemicals, and contract services.

  • 251 - 500

Highlights

Total Funding Amount
$1.50M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 1980
Number Of Employee
251 - 500
Operating Status
Active

Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.50M
Cayman Chemical has raised a total of $1.50M in funding over 2 rounds. Their latest funding was raised on Apr 25, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 25, 2019 Grant $1.50M 2 National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 		— Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Cayman Chemical is funded by 2 investors. National Institutes of Health and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Yes Grant
Cointime
Содержание
компания